News

CRISPR Therapeutics CRSP and Intellia Therapeutics NTLA are leading developers of therapies that utilize the Nobel ...
Regeneron Pharmaceuticals, Inc. faces challenges with Eylea sales but sees growth from Dupixent and obesity drugs. Click for ...
The Academy Award winner shares how he's staying young at 88—and why he's narrating a new video about a certain heart ...
In this exclusive MedPage Today video, investigator Shahzad Raza, MD, of the Cleveland Clinic Cancer Institute, explains why ...
In May, the company announced the failure of the monoclonal antibody birtamimab to improve mortality in a phase 3 trial of ...
Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.
By clicking “Accept All Cookies”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. You accept for the main domain ...
Join ACC's Cardiovascular Imaging Member Section on Tuesday, Aug. 5 at 5:30 p.m. ET for a case-based, multi-modality webinar of the contemporary cardiovascular imaging evaluation of cardiac ...
Accumulation of fibrils composed of amyloid A in tissues resulting in displacement of normal structures and cellular dysfunction is the characteristic feature of systemic amyloidoses. Here we show ...
The efficacy of florbetaben (18F) in diagnosing cardiac amyloidosis is being evaluated in an ongoing multi-center Phase 3 study; BERLIN, June 12, 2025 /PRNewswire/ -- Life Molecular Imaging GmbH ...
Florbetaben (18F) has been granted Orphan drug designation for the diagnosis of ATTR amyloidosis Florbetaben (18F) previously received orphan drug designation as a diagnostic agent for the ...